No Data
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript
Analysts' Top Healthcare Picks: Opko Health (OPK), Pharming Group (PHAR)
OPKO Health Price Target Maintained With a $3.00/Share by HC Wainwright & Co.
OPKO Health Price Target Maintained With a $3.00/Share by HC Wainwright & Co.
HC Wainwright & Co. Reiterates Buy on OPKO Health, Maintains $3 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates OPKO Health (NASDAQ:OPK) with a Buy and maintains $3 price target.
OPKO Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 154.24% HC Wainwright & Co. → $3 Reiterates Buy → Buy 04/03/2024 154.24% HC Wainwright & Co. →